Neurocrine Biosciences (NBIX) Shares Issued (2016 - 2021)
Historic Shares Issued for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to $1.8 million.
- Neurocrine Biosciences' Shares Issued fell 526.32% to $1.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $27.5 million, marking a year-over-year decrease of 549.83%. This contributed to the annual value of $122.1 million for FY2024, which is 8698.32% up from last year.
- Latest data reveals that Neurocrine Biosciences reported Shares Issued of $1.8 million as of Q4 2021, which was down 526.32% from $7.5 million recorded in Q3 2021.
- Neurocrine Biosciences' 5-year Shares Issued high stood at $16.1 million for Q1 2018, and its period low was $1.5 million during Q1 2017.
- Its 5-year average for Shares Issued is $6.6 million, with a median of $5.4 million in 2018.
- As far as peak fluctuations go, Neurocrine Biosciences' Shares Issued surged by 878888.89% in 2017, and later tumbled by 8467.74% in 2020.
- Neurocrine Biosciences' Shares Issued (Quarter) stood at $5.6 million in 2017, then crashed by 68.71% to $1.8 million in 2018, then soared by 607.76% to $12.4 million in 2019, then plummeted by 84.68% to $1.9 million in 2020, then decreased by 5.26% to $1.8 million in 2021.
- Its Shares Issued stands at $1.8 million for Q4 2021, versus $7.5 million for Q3 2021 and $3.0 million for Q2 2021.